NEJM Interviews

NEJM Group
  • 4,9 (8)
  • MEDICINA
  • QUINZENAL

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

  1. HÁ 1 DIA

    NEJM Interview: Leemore Dafny on the implications of corporatization of the U.S. health insurance industry.

    Leemore Dafny is a professor of business administration at Harvard Business School and a professor of public policy at the Harvard Kennedy School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L. Dafny. Health Insurance after Corporatization — What Next? N Engl J Med 2026;394:521-523.

    11min

  2. 28 DE JAN.

    NEJM Interview: Robert Kocher on strategies for improving blood-pressure control in the United States.

    Robert Kocher is an adjunct professor at the Stanford University School of Medicine, a nonresident senior scholar at the University of Southern California Schaeffer Institute, and a partner at Venrock. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.P. Kishore and R. Kocher. The Hypertension Control Paradox — Why Is America Stuck? N Engl J Med 2026;394:417-420.

    7min

  3. 21 DE JAN.

    NEJM Interview: Tara Eicher on changes in autism diagnosis in recent years and statements from the federal government regarding autism.

    Tara Eicher is a postdoctoral research fellow in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Eicher, J. Quackenbush, and A. Ne’eman. Challenging Claims of an Autism Epidemic — Misconceptions and a Path Forward. N Engl J Med 2026;394:313-315.

    14min

  4. 14 DE JAN.

    NEJM Interview: Tara Sklar on U.S. telehealth payment policy and the potential for a revised approach to support competition and efficiency.

    Tara Sklar is the faculty director of the Health Law and Policy Program at the University of Arizona James E. Rogers College of Law and associate director of telehealth law and policy at the University of Arizona College of Medicine–Tucson Arizona Telemedicine Program. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Sklar and B. Richman. Financing Telehealth — Moving Beyond Payment Parity. N Engl J Med 2026;394:211-213.

    12min

  5. 7 DE JAN.

    NEJM Interview: Rachel Sachs on recent agreements governing coverage and pricing of GLP-1 receptor agonists in the United States.

    Rachel Sachs is a professor of law at Washington University in St. Louis. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina and R.E. Sachs. Insurance Coverage and Pricing of Weight-Loss Drugs in the United States. N Engl J Med 2026;394:105-107. S. Gondi, A.S. Kesselheim, and B.N. Rome. Generic Liraglutide — Overlooked but Not Forgotten. N Engl J Med. DOI: 10.1056/NEJMp2515668.

    11min

  6. 31/12/2025

    NEJM Interview: Ambar La Forgia on the drivers and effects of corporatization of outpatient medical services.

    Ambar La Forgia is an assistant professor in the Management of Organizations group at the University of California, Berkeley Haas School of Business. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A. La Forgia. From Patients to Consumers — The Corporatization of Ambulatory Care. N Engl J Med 2026;394:1-3.

    10min

  7. 17/12/2025

    NEJM Interview: Anne Zink on increases in rates of congenital syphilis and potential strategies for reversing this trend.

    Anne Zink is a lecturer and senior fellow at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.B. Zink, N.C. McCann, and R.P. Walensky. From Crisis to Action — Policy Pathways to Reverse the Rise in Congenital Syphilis. N Engl J Med 2025;393:2388-2391.

    8min

  8. 10/12/2025

    NEJM Interview: Reshma Ramachandran on changes to the FDA’s adverse-event data releases and future directions for enhancing its safety-surveillance infrastructure.

    Reshma Ramachandran is an assistant professor of medicine at the Yale School of Medicine. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.D. Wallach, J.S. Ross, and R. Ramachandran. Enhancing FDA Drug-Safety Surveillance — Beyond Releasing Daily Adverse-Event Data. N Engl J Med 2025;393:2284-2286.

    10min
Ver tudo (923)

Classificações e avaliações

4,9
de 5
8 avaliações

Sobre

Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.

Informações

  • Canal
    NEJM Group
  • Criado por
    NEJM Group
  • Anos de atividade
    2006 - 2026
  • Episódios
    923
  • Classificação
    Livre
  • Copyright
    © Copyright 2026 Massachusetts Medical Society
  • Site do podcast
    NEJM Interviews

Mais de NEJM Group

Você também pode gostar de